Theriva Biologics TOVX
NYSE TOVX
$0.21 +0.00 (+0.19%)
As of: Oct 21, 2026 · 12:52 PM EDT

Theriva Biologics (TOVX) Total Current Liabilities (2010 - 2026)

Updated

Theriva Biologics (TOVX) reported Total Current Liabilities of $12.11 million for Q2 2026, down 2.3% from $12.39 million a year earlier but up 18.0% from the prior quarter.

Analysis

Theriva Biologics (TOVX) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Theriva Biologics posted Total Current Liabilities of $10.01 million, up 32.0% from FY2024.

  • Total Current Liabilities has a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $7.59 million in FY2024 (+12.6%), $6.74 million in FY2023 (-4.6%), $7.06 million in FY2022 (+98.6%) and $3.55 million in FY2021 (+19.8%).
  • Five-year quarterly Total Current Liabilities spans a low of $3.16 million in Q3 2021 and a high of $12.42 million in Q2 2022.
  • Year over year, Total Current Liabilities gained in six of the last eight quarters, with growth averaging 27.4%.
  • The high point for year-over-year Total Current Liabilities in five years was Q2 2022 (growth of 491.9%); the low point was Q1 2024 (a decline of 30.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $10.26 million (Q1 2026), $10.01 million (Q4 2025) and $11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn 54.90 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn 41.64 Bn
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 31.55 Bn
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn 11.02 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 32.65 Bn
10 Theriva Biologics 9.56 Mn -36.79 Mn - 12.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.11 Mn
Mar 31, 2026 10.26 Mn
Dec 31, 2025 10.01 Mn
Sep 30, 2025 11.00 Mn
Jun 30, 2025 12.39 Mn
Mar 31, 2025 8.15 Mn
Dec 31, 2024 7.59 Mn
Sep 30, 2024 7.32 Mn
Jun 30, 2024 6.85 Mn
Mar 31, 2024 6.01 Mn
Dec 31, 2023 6.74 Mn
Sep 30, 2023 8.74 Mn
Jun 30, 2023 9.13 Mn
Mar 31, 2023 8.62 Mn
Dec 31, 2022 7.06 Mn
Sep 30, 2022 12.32 Mn
Jun 30, 2022 12.42 Mn
Mar 31, 2022 10.98 Mn
Dec 31, 2021 3.55 Mn
Sep 30, 2021 3.16 Mn
API Access

Theriva Biologics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TOVX&period=max&api_key=YOUR_API_KEY